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Abstract
Background: Influenza	 virus	 circulation	 is	 monitored	 through	 the	 Cambodian	 in-
fluenza-like	 illness	 (ILI)	 sentinel	 surveillance	 system	 and	 isolates	 are	 characterized	
by	 the	 National	 Influenza	 Centre	 (NIC).	 Seasonal	 influenza	 circulation	 has	 previ-
ously	been	characterized	by	year-round	activity	and	a	peak	during	the	rainy	season	
(June-November).
Objectives: We	documented	the	circulation	of	seasonal	 influenza	 in	Cambodia	 for	
2012-2015	and	investigated	genetic,	antigenic,	and	antiviral	resistance	characteris-
tics	of	influenza	isolates.
Patients/Methods: Respiratory	 samples	 were	 collected	 from	 patients	 presenting	
with	influenza-like	illness	(ILI)	at	11	hospitals	throughout	Cambodia.	First-line	screen-
ing	was	conducted	by	the	National	Institute	of	Public	Health	and	the	Armed	Forces	
Research	 Institute	 of	Medical	 Sciences.	Confirmation	of	 testing	 and	 genetic,	 anti-
genic	 and	antiviral	 resistance	characterization	was	conducted	by	 Institute	Pasteur	
in	Cambodia,	the	NIC.	Additional	virus	characterization	was	conducted	by	the	WHO	
Collaborating	Centre	for	Reference	and	Research	on	Influenza	(Melbourne,	Australia).
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1  | BACKGROUND
Influenza	 viruses	 belong	 to	 the	Orthomyxoviridae	 family	 of	 envel-
oped,	 segmented	 negative-stranded	 RNA	 viruses.	 Currently,	 four	
antigenically	 distinct	 influenza	 viruses	 are	 responsible	 for	 human	
seasonal	influenza	infections,	including	two	subtypes	of	influenza	A	
[A(H1N1)pdm09	and	A(H3N2)]	and	two	lineages	of	influenza	B	(B/
Yamagata	and	B/Victoria).	 Influenza	 is	 responsible	 for	a	 large	pro-
portion	of	human	morbidity	and	mortality	as	a	result	of	 infections	
worldwide.	 Annual	 influenza	 infections	 are	 estimated	 to	 result	 in	
approximately	 3	 to	 5	million	 cases	 of	 severe	 illness	 globally,1 and 
290	000	to	650	000	deaths.2
Seasonal	influenza	epidemics	occur	every	year	in	temperate	re-
gions	during	 the	winter	months3:	November	 to	March/April	 in	 the	
northern	hemisphere	and	May	to	September	in	the	southern	hemi-
sphere.4,5	Influenza	seasonality	is	more	variable	in	tropical/subtrop-
ical	regions	where	circulation	can	be	observed	year-round,	although	
activity	is	often	more	intense	during	rainy	seasons.6	In	addition,	in-
fluenza	activity	is	punctuated	by	occasional	pandemics	arising	from	
the	introduction	of	novel	influenza	A	viruses	into	human	circulation.	
These	pandemics	can	significantly	increase	morbidity	and	mortality	
worldwide,	with	major	economic	impacts.7
We	 have	 previously	 described	 the	 circulation	 and	 seasonal-
ity	 of	 influenza	 viruses	 in	 Cambodia	 during	 six	 consecutive	 years	
(2006-2011)	following	the	establishment	of	the	Cambodian	National	
Influenza	 Centre	 (NIC)	 in	 2006.8-10	 These	 previous	 data	 demon-
strated	a	peak	in	influenza	circulation	during	the	rainy	season	from	
June	 to	 November,	 which	 is	 consistent	 with	 influenza	 circulation	
in	 the	 southern	 hemisphere.	However,	 year-round	 circulation	was	
also	 described,	 characteristic	 of	 influenza	 seasonality	 in	 tropical/
subtropical	 regions,	 including	 some	 other	 Southeast	 Asian	 coun-
tries.11,12	This	current	study	furthers	our	understanding	of	influenza	
in	Cambodia	and	describes	the	seasonal	circulation,	genetic	and	anti-
genic	diversity,	and	antiviral	drug	susceptibility	analyses	of	influenza	
viruses	in	Cambodia	during	four	consecutive	years	(2012-2015).
2  | MATERIAL S AND METHODS
2.1 | Ethical statement
The	 Cambodian	 ILI	 surveillance	 system	 is	 a	 public	 health	 activity	
managed	by	 the	Ministry	of	Health	 in	Cambodia	and	has	a	 stand-
ing	 authorization	 from	 the	National	 Ethics	 Committee	 for	Human	
Research.	Samples	and	patient	information	were	anonymized	for	the	
purpose	of	this	surveillance.
2.2 | Geographic background
Cambodia	is	a	tropical	climate	country	in	Southeast	Asia	with	more	
than	15.5	million	people,	 situated	 in	 the	southwestern	part	of	 the	
Indochina	peninsula	and	sharing	international	borders	with	Thailand	
and	 Laos	 on	 the	West	 and	 North,	 and	 Vietnam	 on	 the	 East	 and	
Southeast.13	The	country	 is	affected	by	the	Asian	monsoon	and	 is	
mostly	hot	and	humid	with	a	mean	temperature	of	27ºC	and	mean	
relative	 humidity	 of	 77.5%.	 Similar	 to	 other	 subtropical/tropical	
areas,	 Cambodia	 has	 two	 distinct	 seasons:	 the	 dry	 season,	 which	
generally	runs	from	November	to	April;	and	the	rainy	season,	which	
starts	in	May-June	and	ends	in	October-November.
2.3 | ILI surveillance system in Cambodia
The	 Cambodian	 National	 Influenza	 Center	 (NIC)	 was	 established	
in	August	 2006	 at	 the	 Institute	 Pasteur	 in	Cambodia	 (IPC).	 It	 is	 a	
joint	collaboration	between	IPC,	the	Communicable	Disease	Control	
Department	of	the	Ministry	of	Health	 (CDC/MoH),	and	the	World	
Health	Organization	(WHO)	office	in	Cambodia	for	documenting	the	
dynamics	of	influenza	disease	and	conducting	virological	characteri-
zation	of	circulating	influenza	strains.
An	outpatient	 sentinel	 surveillance	 system	 for	 influenza-like	 ill-
ness	 (ILI)	with	a	weekly	reporting	and	sampling	scheme	was	estab-
lished.	Six	ILI	sentinel	surveillance	sites	were	operated	in	the	referral	
Results: Between	2012	and	2015,	1,238	influenza-positive	samples	were	submitted	
to	 the	NIC.	 Influenza	A(H3N2)	 (55.3%)	was	 the	dominant	 subtype,	 followed	by	 in-
fluenza	B	 (30.9%;	predominantly	B/Yamagata-lineage)	and	A(H1N1)pdm09	(13.9%).	
Circulation	of	influenza	viruses	began	earlier	in	2014	and	2015	than	previously	de-
scribed,	coincident	with	the	emergence	of	A(H3N2)	clades	3C.2a	and	3C.3a,	respec-
tively.	There	was	high	diversity	in	the	antigenicity	of	A(H3N2)	viruses,	and	to	a	smaller	
extent	influenza	B	viruses,	during	this	period,	with	some	mismatches	with	the	north-
ern	and	southern	hemisphere	vaccine	formulations.	All	isolates	tested	were	suscepti-
ble	to	the	influenza	antiviral	drugs	oseltamivir	and	zanamivir.
Conclusions: Seasonal	and	year-round	co-circulation	of	multiple	influenza	types/sub-
types	were	detected	in	Cambodia	during	2012-2015.
K E Y W O R D S
A(H1N1)pdm09,	A(H3N2),	Cambodia,	influenza	A	virus,	influenza	B	virus,	surveillance
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hospitals	of	Kampong	Cham	(Eastern	Cambodia),	Mondulkiri	(Eastern	
Cambodia),	Svay	Rieng	(Southeast	Cambodia),	and	Kampot	(Southwest	
Cambodia)	Provinces;	and	in	a	children's	hospital	in	Siem	Reap	(north-
western	Cambodia)	and	 in	 the	national	pediatric	hospital	 in	Phnom	
Penh	 (capital	 city	 of	 Cambodia)	 by	 the	CDC/MoH	 in	 collaboration	
with	the	National	 Institute	of	Public	Health	 (NIPH),	with	assistance	
from	the	US	Centers	for	Disease	Control	and	Prevention	and	WHO	
Cambodia.	The	Armed	Forces	Research	Institute	of	Medical	Sciences	
(AFRIMS)	operated	an	additional	five	sentinel	sites	in	northwestern	
Cambodia:	Thmor	Kol	Health	Center	(Battambang	Province),	Ta	Sahn	
Health	Center	(Battambang	Province),	Anlong	Veng	Referral	Hospital	
(Oddar	 Meanchey	 Province),	 Banteay	 Meanchey	 Health	 Center	
(Banteay	Meanchey	Province),	and	Preah	Punlea	Health	Centre	(Pailin	
Province).	The	11	hospital	sites	included	in	the	Cambodian	outpatient	
surveillance	system	for	ILI	are	presented	in	Figure	1.
The	case	definition	for	ILI	was	defined	as	previously	described	by	
WHO:	sudden	onset	of	fever	(≥38ºC	axillary	temperature)	and	cough	
or	sore	throat	in	the	absence	of	other	diagnosis.9,14
2.4 | Specimen collection
Between	January	2012	and	December	2015,	specimens	and	sur-
veillance	 data	 were	 collected	 from	 a	 subset	 of	 outpatients	 pre-
senting	 with	 ILI	 at	 sentinel	 surveillance	 sites.	 During	 2012,	 ILI	
samples	were	collected	as	described	previously.9	Starting	in	2013	
(and	continuing	through	2015),	primary	testing	was	shifted	to	the	
NIPH	and	AFRIMS	laboratories,	with	the	NIC	concentrating	on	ref-
erence	center	activities.	As	such,	during	2013-2015	all	ILI	samples	
were	 first	 screened	by	 the	 laboratories	 at	NIPH	or	AFRIMS	 and	
then	influenza-positive	samples	 (plus	~30%	negative	samples	for	
F I G U R E  1  Map	of	Cambodia	showing	
the	influenza-like	illness	sentinel	
surveillance	sites	and	supporting	
laboratories.	ILI,	influenza-like	illness;	
AFRIMS,	Armed	Forces	Research	Institute	
of	Medical	Sciences;	NIPH,	National	
Institute	of	Public	Health;	IPC,	Institute	
Pasteur	in	Cambodia;	NIC,	National	
Influenza	Centre
LAO PDR
Legend*
ILI Sites
AFRIMS laboratories
NIPH laboratories
IPC/NIC laboratories
TA B L E  1  The	detection	and	isolation	of	influenza	viruses	associated	with	influenza-like	illness	(ILI)	in	Cambodia	during	2012-2015
 
Samples re‐
ceived by NIC
Influenza‐positive samples Successful influenza isolationa,b Isolates sent to WHO CC
H1N1pdm09 H3N2
Influenza 
B Total H1N1pdm09 H3N2
Influenza 
B H1N1pdm09 H3N2
Influenza 
B
2012 1907c 26 218 80 324 6 88 50 0 37 1
2013 467 91 24 220 335 63 9 154 55 7 51
2014 404 36 212 15 263 33 174 11 11 30 3
2015 444 19 230 67 316 13 123 61 7 21 10
Total 3222 172 684 382 1238 115 194 276 73 95 65
aInfluenza	viruses	were	isolated	in	Madin-Darby	canine	kidney	(MDCK)	cells.	
bVirus	isolation	was	only	attempted	on	samples	with	high	viral	load,	as	determined	by	RT-qPCR	CT	values.	
cDuring	2012	first-line	screening	was	conducted	by	the	National	Influenza	Centre	(NIC).	
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quality	control	testing)	were	forwarded	to	the	NIC	for	confirma-
tion	and	viral	characterization.
2.5 | Laboratory methods
At	the	NIC,	viral	RNA	was	extracted	using	the	QIAamp	Viral	RNA	Mini	
Kit	(Qiagen,	CA,	USA)	and	amplified	using	real-time	RT-PCR	to	detect	
influenza	A	and	B	viruses	using	standard	protocols.	Influenza	A	viruses	
were	subsequently	subtyped	using	subtype-specific	real-time	reverse	
transcriptase	polymerase	chain	 reaction	 (RT-qPCR)	assays	 targeting	
H1pdm,	H1,	H3,	H5,	H7,	N1pdm,	N1,	and	N2	genes.8,9	All	 influenza	
primers	were	sourced	from	the	International	Reagent	Resource	(https	
://www.inter	natio	nalre	agent	resou	rce.org/Home.aspx).
Influenza	 viruses	were	 isolated	 at	 the	 IPC	 laboratory	 by	 inoc-
ulation	of	 the	 specimens	 that	 tested	positive	by	 real-time	RT-PCR	
onto	Madin-Darby	canine	kidney	(MDCK)	cells	in	an	enhanced	bio-
safety	level	2	laboratory.9	The	influenza	isolates	were	characterized	
by	hemagglutination	inhibition	assay	(HAI)	using	reference	antigens	
and	anti-sera	provided	by	the	WHO	Collaborating	Center	(WHOCC)	
for	 Reference	 and	Research	 on	 Influenza	 in	Melbourne,	Australia.	
A	representative	number	of	 influenza	isolates	were	sent	each	year	
to	the	WHOCC	in	Melbourne	for	confirmation	and	further	analysis,	
including	antiviral	testing	and	partial	or	full	genome	sequencing	of	
representative	viruses.
2.6 | Genome sequencing and phylogenetic analysis
Viral	RNA	extracted	from	MDCK	supernatant	was	used	to	sequence	
the	 HA	 gene	 of	 all	 influenza	 isolates	 at	 the	 NIC	 laboratory	 using	
Sanger	sequencing.	At	the	WHOCC	(Melbourne),	a	single-reaction,	
F I G U R E  2  Number	of	specimens	positive	for	influenza	by	subtype	in	Cambodia	2012-2015	by	week.	Cambodian	data	
accessed	from	the	Global	Initiative	on	Sharing	All	Influenza	Data	(GISAID—https	://www.gisaid.org/)
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multiplex	RT-PCR	method	that	amplifies	the	HA,	NA,	and	M	genomic	
segments	 of	 seasonal	 influenza	 A	 and	 B	 viruses	 for	 next-genera-
tion	 sequencing	 was	 used,	 as	 previously	 described.15	 Nucleotide	
sequences	 from	 the	 coding	 regions	 of	 the	HA	 genes	 of	 A(H3N2),	
A(H1N1)pdm09,	and	influenza	B	viruses	were	aligned	using	the	Mafft	
multiple	 aligner	V1.3.7	 in	 the	Geneious	V10.0.9	 software	package	
(www.genei	ous.com).	 Sequences	 originating	 from	 Cambodia,	 sur-
rounding	 countries,	 and	 representative	 reference	 sequences	were	
downloaded	from	the	EpiFlu™	Database	(www.gisaid.org).	Maximum	
likelihood	trees	were	estimated	using	PhyML	3.016	with	1000	boot-
strap	 replicates	 using	 the	 ATGC	 server	 (http://www.atgc-montp	
ellier.fr/phyml/	execu	tion).	The	most	appropriate	nucleotide	 substi-
tution	method	determined	for	each	data	set	was	the	GTR	+	G	model.
The	complete	matrix	gene	was	sequenced	from	representative	
influenza	A	viruses	using	previously	described	methods,15	to	ascer-
tain	the	presence	of	mutations	(eg,	Ser31Asn)	associated	with	resis-
tance	to	the	adamantine	class	of	inhibitors.
2.7 | Nucleotide sequence accession numbers
All	 Cambodian	 influenza	 A(H3N2),	 A(H1N1)pdm09,	 and	 influenza	
B	 viral	 sequences	 included	 in	 the	 analysis	 were	 submitted	 to	 the	
EpiFlu™	Database,	and	all	of	these	sequences	are	available	via	the	
GISAID	 website	 (https	://www.gisaid.org/).	 Table	 S1	 provides	 de-
tailed	information	about	all	of	the	Cambodian	isolates	and	sequences	
analyzed	in	this	study.
2.8 | Antiviral susceptibility testing
All	 influenza	 isolates	sent	each	year	 to	the	WHOCC	in	Melbourne	
were	analyzed	for	neuraminidase	 (NA)	 inhibitor	susceptibility	 test-
ing	using	an	enzyme	 inhibition	assay	utilizing	 the	 fluorescent	 sub-
strate	 MUNANA	 as	 described	 previously.17	 The	 concentration	 of	
drug	required	to	inhibit	50%	of	the	NA	activity	(IC50)	was	calculated	
using	the	non-linear	curve	fitting	function	in	the	GraphPad	Prism	4	
package	(GraphPad	Software).	The	average	IC50	(nM)	(±	standard	de-
viation)	of	two	independent	determinations	was	calculated	for	each	
virus.	Outliers	of	more	than	two	standard	deviations	from	the	overall	
mean	were	 retested	 twice.18	 Antiviral	 susceptibility	was	 classified	
according	to	the	guidelines	from	the	WHO	working	group	on	surveil-
lance	of	influenza	antiviral	susceptibility.18
2.9 | Statistical analysis
The	comparisons	between	percentages	and	two	means	were	tested	
by	chi-squared	(χ2)	and	Student's	t	test,	respectively.	A	p	value	<	0.05	
TA B L E  2  The	seasonal	influenza	strains	circulating	in	Cambodia	(2012-2015)	compared	to	the	strains	included	in	the	WHO-
recommended	vaccine	formulations	for	trivalent	influenza	vaccines;	viruses	in	bold	indicate	where	the	dominant	Cambodian	strain	matched	
the	vaccine	strain
Year Virus
Trivalent inactivated influenza vaccine strains
Cambodian circulating strainsb 
(proportion of Cambodian isolates)Northern hemispherea Southern hemisphere
2012 A/H1N1pdm09 A/California/7/2009‐like A/California/7/2009‐like A/California/7/2009‐like (100%)
A/H3N2 A/Perth/16/2009-like A/Perth/16/2009-like A/Victoria/361/2011-like	(91%)	 
A/Perth/16/2009-like	(9%)
Influenza	B B/Brisbane/60/2008-like B/Brisbane/60/2008-like B/Wisconsin/1/2010-like	(70%) 
B/Brisbane/60/2008-like	(30%)
2013 A/H1N1pdm09 A/California/7/2009‐like A/California/7/2009‐like A/California/7/2009‐like (100%)
A/H3N2 A/Victoria/361/2011‐like A/Victoria/361/2011‐like A/Victoria/361/2011‐like (100%)
Influenza	B B/Wisconsin/1/2010‐like B/Wisconsin/1/2010‐like B/Wisconsin/1/2010‐like (52%) 
B/Massachusetts/2/2012-like	(43%) 
B/Brisbane/60/2008-like	(5%)
2014 A/H1N1pdm09 A/California/7/2009‐like A/California/7/2009‐like A/California/7/2009‐like (100%)
A/H3N2 A/Victoria/361/2011-like A/Texas/50/2012‐like A/Texas/50/2012‐like (69%) 
A/Victoria/361/2011-like	(30%) 
A/Switzerland/9715293/2013-like	(1%)
Influenza	B B/Massachusetts/2/2012‐like B/Massachusetts/2/2012‐like B/Massachusetts/2/2012‐like (100%)
2015 A/H1N1pdm09 A/California/7/2009‐like A/California/7/2009‐like A/California/7/2009‐like (100%)
A/H3N2 A/Texas/50/2012-like A/Switzerland/9715293/2013‐like A/Switzerland/9715293/2013‐like	(76%) 
A/Hong	Kong/4801/2014-like	(24%)
Influenza	B B/Massachusetts/2/2012-like B/Phuket/3073/2013‐like B/Phuket/3073/2013‐like (96%) 
B/Brisbane/60/2008-like	(4%)
aNorthern	Hemisphere	vaccination	periods	occur	mid-year	that	is	2012	(2011/2012);	2013	(2012/2013);	2014	(2013/2014);	2015	(2014/2015).	
bB/Brisbane/60/2008-like	viruses	belong	to	the	B/Victoria	/7/87	lineage.	B/Wisconsin/1/2010-like	viruses,	B/Massachusetts/2/2012-like	viruses,	
and	B/Phuket/3073/2013-like	viruses	belong	to	the	B/Yamagata/16/88	lineage.	
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was	considered	statistically	significant.	Proportions,	means,	and	all	
statistical	analyses	were	performed	using	STATA	9.0	(Statacorp).
3  | RESULTS
3.1 | Influenza activity in Cambodia
During	 2012-2015,	 3,222	 specimens	 were	 submitted	 to	 the	
Cambodian	NIC	and	analyzed	as	part	of	the	ILI	surveillance	system	
(Table	1).	Influenza	virus	was	detected	in	1,238	samples	during	this	
period:	 324	 in	2012,	 335	 in	2013,	 263	 in	2014,	 and	316	 in	2015.	
Influenza	A	viruses	(n	=	856,	69.1%)	were	detected	more	frequently	
than	 influenza	 B	 viruses	 (n	 =	 382,	 30.9%).	 A(H1N1)pdm09	 and	
A(H3N2)	viruses	constituted	20.1%	(n	=	172)	and	79.9%	(n	=	684)	of	
influenza	A	virus	subtypes	detected,	respectively.
Co-circulation	of	A(H1N1)pdm09,	A(H3N2),	and	 influenza	B	vi-
ruses	were	detected	across	all	 four	years,	with	A(H3N2)	being	the	
dominant	subtype	in	2012,	2014,	and	2015;	and	influenza	B	the	dom-
inant	virus	in	2013.	Both	lineages	of	influenza	B	virus,	B/Yamagata	
and	B/Victoria,	were	detected	across	all	four	years,	except	in	2013	
where	 only	 the	 B/Yamagata-lineage	 was	 detected.	 From	 2012	 to	
2015,	 influenza	seasonality	varied,	with	peak	circulation	occurring	
from	September	to	December	in	2012	and	2013;	and	from	May	to	
August	in	2014	and	2015	(Figure	2).
Of	 the	 samples	 tested,	 the	 average	 age	 of	 influenza	 patients	
was	8.8	years	(range,	4	days	to	77	years)	and	55.2%	were	male.	The	
age	and	gender	distribution	of	each	year	and	across	the	four	testing	
years	(2012-2015)	for	influenza	patients	are	presented	in	Table	S2.
3.2 | Antigenic analysis
Generally,	 Cambodian	 seasonal	 influenza	 virus	 isolates	 matched	
the	 southern	 hemisphere	 trivalent	 inactivated	 influenza	 vac-
cine	 (TIIV)	 formulations	 during	 the	 relevant	 year	 they	 were	 re-
leased	(Table	2).	Antigenic	analysis	revealed	that	all	of	the	A(H1N1)
pdm09	 isolates	 circulating	 in	 Cambodia	 during	 2012-2015	 be-
longed	 to	 the	 A/California/7/2009(H1N1)-like	 group.	 Mismatches	
occurred	 in	 2012	 when	 an	 A/Perth/16/2009(H3N2)-like	 virus	
was	 included	 in	 both	 of	 the	 northern	 and	 southern	 hemisphere	
TIIVs,	 but	A/Victoria/361/2011(H3N2)-like	 viruses	were	 the	domi-
nant	 circulating	 strains;	 also	 in	 2012,	 a	 B/Brisbane/60/2008-like	
virus	 was	 included	 in	 both	 of	 the	 northern	 and	 southern	 hemi-
sphere	 TIIVs,	 but	 B/Wisconsin/1/2010-like	 was	 the	 dominant	
strain;	 in	 2014,	 the	 northern	 hemisphere	 formulation	 of	 TIIVs	 in-
cluded	 an	 A/Victoria/361/2011(H3N2)-like	 virus,	 but	 the	 domi-
nant	 strain	 in	 Cambodia	 was	 A/Texas/50/2012(H3N2)-like	 (which	
matched	 the	 southern	 hemisphere	 formulation);	 in	 2015,	 an	 A/
Texas/50/2012(H3N2)-like	virus	was	included	in	the	northern	hemi-
sphere	formulation	of	TIIVs,	but	A/Switzerland/9715293/2013(H3N2)-
like	viruses	were	the	dominant	strains	(which	matched	the	southern	
hemisphere	formulation);	also	 in	2015,	a	B/Massachusetts/2/2012-
like	was	included	in	the	northern	hemisphere	formulations	of	TIIVs,	
but	the	dominant	circulating	viruses	were	B/Phuket/3073/2013-like	
(which	matched	the	southern	hemisphere	formulation).
3.3 | Neuraminidase inhibitor susceptibility analysis
A	total	of	148	A(H3N2),	73	A(H1N1)pdm09,	and	83	influenza	B	vi-
ruses	were	tested	for	susceptibility	to	the	neuraminidase	inhibitors	
oseltamivir	and	zanamivir.	The	analysis	demonstrated	that	all	of	the	
tested	isolates	were	sensitive	to	both	drugs	(Table	S4).	Full	NA	gene	
sequences	were	also	generated	for	68	A(H3N2),	25	A(H1N1)pdm09,	
and	48	influenza	B	viruses	and	confirmed	that	none	contained	muta-
tions	associated	with	NA	inhibitor	resistance	(Table	S3).
3.4 | Sequence analysis of the matrix gene for 
mutations associated with amantadine resistance
Sequencing	 of	 the	matrix	 gene	was	 completed	 for	 representative	
A(H1N1)pdm09	(n	=	27)	and	A(H3N2)	(n	=	66)	viruses	from	2012	to	
2015.	Sequence	analysis	showed	that	all	of	the	Cambodian	isolates	
contained	an	amino	acid	change	from	serine	to	asparagine	at	posi-
tion	31	(Ser31Asn)	in	the	M2	protein,	which	is	associated	with	resist-
ance	to	the	adamantine	class	of	inhibitors	(Tables	S4	and	S5).
3.5 | Phylogenetic analysis of A(H1N1)
PDm09 Isolates
Phylogenetic	analysis	of	the	HA	gene	sequences	was	carried	out	for	
70	 representative	 Cambodian	 A(H1N1)pdm09	 isolates	 from	 2012	
to	2015	(Figure	3;	GISAID	accession	numbers	are	listed	in	Table	S1).	
The	HA	 sequences	 for	 clade	 reference	 strains	 (A/Darwin/56/2013,	
A/Michigan/45/2015,	 and	A/South	Australia/22/2015)	and	 the	vac-
cine	strain	(A/California/07/2009)	were	also	included	in	the	phyloge-
netic	analysis.	All	Cambodian	A(H1N1)pdm09	isolates	clustered	with	
clade	6B.1	viruses,	except	one	isolate	(A/Cambodia/W1101376/2012)	
which	 was	 isolated	 in	 2012	 and	 grouped	 with	 the	 reference	 strain	
A/Darwin/56/2013	 in	 clade	 6B.2.	 Interestingly,	 three	 Cambodian	
A(H1N1)pdm09	 isolates	 from	 2015	 were	 grouped	 with	 the	 refer-
ence	strain	A/Michigan/45/2015	from	clade	6B.1.	All	specific	amino	
acid	changes	corresponding	to	each	group	of	viruses	are	indicated	in	
Figure	3.
F I G U R E  3  Phylogenetic	analysis	of	the	HA	genes	(sequences	of	1650	nucleotides	(nt49–1698))	of	influenza	A(H1N1)pdm09	virus	
isolates	collected	in	Cambodia	from	2012	to	2015.	The	phylogenetic	analysis	was	conducted	as	a	maximum	likelihood	phylogenetic	tree	of	
influenza	using	the	GTR	+	G	nucleotide	substitution	model	with	1000	bootstrap	replicates	(values	given	on	the	branches)	and	rooted	to	A/
California/07/2009.	Major	amino	acid	changes	are	shown	in	block	letter	at	the	appropriate	nodes.	Year	of	isolation	is	indicated	by	color:	
2012—blue,	2013—green,	2014—yellow,	2015—purple.	Vaccine	strains	are	indicated	in	bold	red.	Other	reference	viruses	are	indicated	in	
black.	Scale	bar	indicates	the	number	of	nucleotide	substitution	per	site
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3.6 | Phylogenetic analysis of A(H3N2) isolates
Phylogenetic	analysis	of	the	HA	gene	sequences	was	carried	out	
for	 108	 representative	 A(H3N2)	 isolates	 from	 2012	 to	 2015	 in	
Cambodia.	Additional	reference	sequences	corresponding	to	vac-
cine	candidate	strains	and	A(H3N2)	clade	reference	strains	were	
included	in	the	analysis.	HA	sequences	of	the	A(H3N2)	viruses	iso-
lated	 during	 the	 four	 consecutive	 seasons	 fell	 into	 four	 distinct	
clusters	corresponding	with	each	new	influenza	season	(Figure	4;	
GISAID	accession	numbers	are	listed	in	Table	S1):	clade	3C.1	con-
tained	the	majority	of	isolates	from	2012;	clade	3C.3b	contained	
two	 viruses	 isolated	 in	 2013	 (A/Cambodia/X0828305/2013	 and	
A/Cambodia/X0906313/2013)	 and	 some	 isolates	 from	 2014;	
clade	3C.3a	contained	most	of	the	isolates	obtained	in	2014;	and	
clade	 3C.2a	 contained	 two	 isolates	 from	 2012	 (A/Cambodia/
W1023355/2012	 and	 A/Cambodia/W0718409/2012),	 some	
isolates	 from	 2013,	 two	 isolates	 from	 2014	 (A/Cambodia/
Y1204313/2014	 and	 A/Cambodia/Y1218307/2014),	 and	 all	 iso-
lates	 obtained	 in	 2015.	 The	 viruses	 in	 clade	 3C.1	 were	 closely	
related	to	 the	vaccine	strain	A/Texas/50/2012.	The	two	 isolates	
from	2013	 and	 some	 isolates	 from	2014	 that	 belonged	 to	 clade	
3C.3b	 contained	 four	 more	 mutations	 compared	 to	 clade	 3C.1.	
The	 Cambodian	 A(H3N2)	 viruses	 isolated	 in	 2014	 diverged	 into	
two	 clades.	 Some	 of	 the	 2014	 viruses	 belonged	 to	 clade	 3C.3b	
with	 the	 reference	 A/Newcastle/22/2014	 strain;	 however,	 the	
majority	 of	 isolates	 from	 2014	 were	 grouped	 with	 the	 vaccine	
strain	A/Switzerland/9715293/2013,	clade	3C.3a.	The	Cambodian	
A(H3N2)	 isolates	 belonging	 to	 clade	3C.2a	were	 represented	by	
the	reference	strain	A/New	Caledonia/104/2014	and	the	vaccine	
strain	A/Hong	Kong/4801/2014.	All	specific	amino	acid	changes	
corresponding	to	each	clade	are	indicated	in	Figure	4.
3.7 | Phylogenetic analysis of influenza B isolates
Phylogenetic	 analysis	 of	 the	 HA	 gene	 sequences	 was	 carried	
out	 for	 56	 representative	 Cambodian	 influenza	 B	 isolates	 from	
2012	 to	 2015	 (Figure	 5;	 GISAID	 accession	 numbers	 and	 listed	
in	Table	S1).	The	Cambodian	 influenza	B	viruses	were	compared	
to	 the	 reference	 strains	 for	B/Yamagata	 (B/Wisconsin/01/2010,	
B/Massachusetts/02/2012,	 and	 B/Phuket/3073/2013),	 and	 B/
Victoria	 (B/Brisbane/60/2008)	 lineages.	 During	 this	 period,	 the	
majority	of	influenza	B	viruses	circulating	in	Cambodia	belonged	to	
the	B/Yamagata-lineage.	However,	Cambodian	influenza	B	isolates	
belonging	 to	 the	B/Victoria-lineage	were	 also	detected	 in	2012,	
2013,	and	2015.	All	of	 the	Cambodian	B/Victoria-lineage	strains	
clustered	with	B/Brisbane/46/2015	(clade	V1.A).	Two	subgroups	
emerged	 within	 the	 Cambodian	 B/Yamagata-lineage.	 One	 sub-
group	(B/Yamagata-lineage,	clade	Y2),	with	most	of	the	Cambodian	
isolates	 collected	 in	 2013	 and	 three	 isolates	 from	 2014,	 was	
closely	 related	 to	 the	 vaccine	 strain	 B/Massachusetts/02/2012.	
The	 other	 subgroup	 of	 Cambodian	 influenza	 B/Yamagata-line-
age	 grouped	 with	 the	 vaccine	 strain	 B/Phuket/3073/2013	 (B/
Yamagata-lineage,	clade	Y3),	which	included	some	of	the	isolates	
collected	 in	 2014	 and	 almost	 all	 isolates	 from	2015.	All	 specific	
amino	 acid	 changes	 corresponding	 to	 each	 group	 of	 viruses	 are	
indicated	in	Figure	5.
4  | DISCUSSION
During	the	surveillance	period	(2012-2015),	influenza	circulation	was	
dominated	by	A(H3N2),	comprising	55%	of	the	viruses	detected,	fol-
lowed	by	influenza	B	(31%;	predominantly	B/Yamagata-lineage)	and	
A(H1N1)pdm09	 (14%).	These	figures	closely	 reflect	 influenza	virus	
circulation	during	this	period	 in	the	WHO	Western	Pacific	Region,	
where	A(H3N2)	(51%),	influenza	B	(32%),	and	A(H1N1)pdm09	(17%)	
were	detected	in	similar	proportions.19
Previous	surveillance	of	influenza	circulation	in	Cambodia	from	
2006-20118-10	 revealed	 a	 consistent	 peak	 during	 the	 Cambodian	
rainy	season	from	June	to	November,	which	broadly	coincided	with	
peak	 influenza	 circulation	 in	 the	 southern	 hemisphere.	 However,	
year-round	 co-circulation	 of	multiple	 influenza	 subtypes	 reflected	
a	 similar	 pattern	 observed	 in	many	 tropical	 countries.	 Hence,	 the	
Cambodian	pattern	of	influenza	transmission	was	postulated	as	in-
termediate	between	the	temperate	southern	hemisphere	and	tropi-
cal	countries.9	These	general	patterns	were	repeated	in	2012-2015.	
However,	 an	 earlier	 peak	 in	 influenza	 circulation	was	 observed	 in	
2014	 (April-August)	 and	 2015	 (June-September),	 which	 coincided	
with	 the	 circulation	 of	 the	 clade	 3C.2a	 and	 3C.3a	 A(H3N2)	 vi-
ruses,	 the	dominant	viruses	 in	 these	seasons,	 respectively.	An	un-
usual,	earlier	peak	in	seasonal	influenza	circulation,	associated	with	
A(H3N2)	 clade	 3C.2a,	 was	 also	 observed	 in	 South	 Korea	 during	
2016-2017.20	There	was	also	some	evidence	of	bimodal	circulation	
during	2014-2015,	particularly	in	2015	when	a	second	peak	in	influ-
enza	 circulation	was	noted	during	October-December,	 linked	with	
an	 increase	 in	 influenza	B	cases.	 In	all	years	 included	 in	the	study,	
except	2014,	influenza	B	viruses	were	primarily	detected	at	the	end	
of	the	influenza	season,	as	influenza	A	cases	were	starting	to	wane.	
This	pattern	of	influenza	B	circulation	has	previously	been	noted	in	
Cambodia	and	other	countries	globally.9,21	Seasonal	influenza	vacci-
nation	is	not	widespread	in	Cambodia,	but	considering	the	co-circu-
lation	of	both	influenza	B	lineages	in	most	years	since	surveillance	
F I G U R E  4  Phylogenetic	analysis	of	the	HA	genes	(sequences	of	1653	nucleotides	(nt49–1701)	of	influenza	A(H3N2)	virus	isolates	
collected	in	Cambodia	from	2012	to	2015.	The	phylogenetic	analysis	was	conducted	as	a	maximum	likelihood	phylogenetic	tree	of	
influenza	using	the	GTR	+	G	nucleotide	substitution	model	with	1000	bootstrap	replicates	(values	given	on	the	branches)	and	rooted	to	A/
Texas/50/2012.	Major	amino	acid	changes	are	shown	in	block	letters	at	the	appropriate	nodes.	Year	of	isolation	is	indicted	by	color:	2012—
blue,	2013—green,	2014—yellow,	2015—purple.	Vaccine	strains	are	indicated	in	bold	red.	Other	reference	viruses	are	indicated	in	black.	
Scale	bar	indicates	the	number	of	nucleotide	substitution	per	site
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began	 in	 2006,8,9	 and	 the	 frequent	mismatch	 between	 strains	 in-
cluded	 in	 the	TIIVs	and	 the	most	dominant	 circulating	 influenza	B	
lineage,	the	introduction	of	the	quadrivalent	seasonal	influenza	vac-
cine	might	be	worthwhile,	especially	in	young	children,	as	this	cov-
ers	both	lineages	of	influenza	B	virus	and	both	subtypes	of	seasonal	
influenza	A	viruses.22
Antigenic	 characterization	 of	 Cambodian	 influenza	 isolates	
from	2012	 to	2015	 largely	 corresponded	with	 the	 southern	 and	
northern	 hemisphere	 vaccine	 formulations.	 Vaccination	 for	 sea-
sonal	 influenza	 is	 still	 rare	 in	Cambodia,	with	 vaccines	 generally	
only	 available	 through	 private	 clinics.9,23	 Future	 policies	 for	 the	
introduction	of	seasonal	vaccination	in	Cambodia	will	be	aided	by	
the	distinct	seasonality	of	 influenza	circulation,	which	 is	unusual	
for	 a	 tropical	 country,	 and	 should	 be	 aligned	with	 a	 vaccination	
program	 mirroring	 the	 WHO	 southern	 hemisphere	 vaccination	
formulation	 timetable	 with	 vaccinations	 ideally	 taking	 place	 in	
March-April.	 Recent	 introduction	 of	 seasonal	 alert	 thresholds	 in	
Cambodia24	using	the	“WHO	method”25	will	also	help	to	refine	the	
ideal	vaccination	timing.
There	was	no	detection	of	 seasonal	 influenza	 isolates	with	 re-
sistance	to	the	commonly	used	antivirals	oseltamivir	and	zanamivir	
in	Cambodia	 during	2012-2015.	 These	 antivirals	 are	 generally	 not	
used	in	Cambodia	during	seasonal	influenza	infections,	so	resistance	
is	 unlikely	 to	 be	 affected	 by	 domestic	 antiviral	 use.	 Following	 the	
widespread	reporting	of	adamantane	resistance	in	A(H3N2)	strains	
from	2005	and	the	emergence	of	the	A(H1N1)pdm09	virus	 (which	
was	 already	 adamantane-resistant),	 this	 antiviral	 is	 no	 longer	 rec-
ommended	for	use.26,27	Sequence	analysis	of	the	matrix	gene	from	
representative	 Cambodian	 isolates	 suggested	 that	 resistance	 to	
adamantanes	is	common,	as	all	isolates	obtained	during	this	period	
contained	the	Ser31Asn	mutation	in	the	M2	protein.	This	situation	is	
still	reflected	currently	with	most	isolates	globally	being	resistant,27 
despite	the	almost	complete	cessation	in	the	use	of	adamantanes.
Samples	from	patients	with	ILI	were	collected	through	two	dif-
ferent	 surveillance	 systems	 (managed	 by	 the	 NIPH	 and	 AFRIMS	
laboratories),	leading	to	limitations	in	the	analyses	presented	in	this	
paper.	However,	any	possible	biases	in	the	representativeness	of	vi-
ruses	are	likely	countered	by	the	large	number	of	samples	collected	
throughout	the	surveillance	period	and	the	large	number	of	sentinel	
sites,	covering	most	of	the	country.	Individual	patient	data	are	com-
piled	at	the	national	level	by	the	Cambodian	Ministry	of	Health	and	
was	not	analyzed	by	the	Cambodian	NIC.	As	such,	epidemiological	
information	such	as	disease	severity	and	infection	rates	could	not	be	
included	 in	 these	analyses.	The	 large	number	of	 influenza-positive	
samples	 (n	=	1,238)	 received	by	 the	NIC	during	 this	period	meant	
that	only	representative	isolates	could	be	included	for	genetic	and	
antigenic	 characterization,	 meaning	 that	 some	 isolates	 with	 inter-
esting	characteristics	could	have	been	missed.	Despite	these	limita-
tions,	we	believe	that	the	results	are	representative	of	the	circulation	
and	genetic/antigenic/antiviral	characteristics	of	seasonal	influenza	
strains	in	Cambodia	during	2012-2015.
Our	data	 concur	with	 the	 findings	 from	previous	 studies	de-
scribing	the	seasonal	circulation	of	influenza	viruses	in	Cambodia	
with	 year-round	 co-circulation	 of	 multiple	 influenza	 sub-
types.8-10,24	Influenza	viruses	detected	in	Cambodia	continued	to	
be	susceptible	to	oseltamivir	and	zanamivir,	but	resistance	to	ad-
amantanes	was	still	universal	in	influenza	A	viruses.	Antigenically,	
there	was	considerable	drift	 in	the	A(H3N2)	viruses	and	some	in	
the	 influenza	 B	 viruses	 (B/Yamagata-lineage	 viruses	 more	 than	
B/Victoria-lineage	 viruses)	 during	 2012-2015,	 but	 little	 change	
in	 A(H1N1)pdm09	 viruses.	 Seasonal	 influenza	 surveillance	 has	
been	strengthened	 in	Cambodia	since	being	established	 in	2006	
and	continues	to	contribute	to	our	knowledge	of	the	regional	and	
global	circulation	of	seasonal	influenza	strains.
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F I G U R E  5  Phylogenetic	analysis	of	the	HA	genes	(sequences	of	1710	nucleotides	(nt	46–1755))	of	influenza	B	virus	isolates	collected	in	
Cambodia	from	2012	to	2015.	The	phylogenetic	analysis	was	conducted	as	a	maximum	likelihood	phylogenetic	tree	of	influenza	using	the	
GTR	+	G	nucleotide	substitution	model	with	1000	bootstrap	replicates	(values	given	on	the	branches)	and	rooted	to	B/Brisbane/60/2008.	
Major	amino	acid	changes	are	shown	in	block	letters	at	the	appropriate	nodes.	Year	of	isolation	is	indicted	by	color:	2012—blue,	2013—
green,	2014—yellow,	2015—purple.	Vaccine	strains	are	indicated	in	bold	red.	Other	reference	viruses	are	indicated	in	black,	and	the	two	
major	lineages	B/Victoria-like	and	B/Yamagata-like	are	shown	on	the	same	figure.	Scale	bar	indicates	the	number	of	nucleotide	substitution	
per	site
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